You guys are over thinking it I reckon. OPTOA will be exercised around the time of the first read out. This will buttress OPT during negotiations. The business will be sold before the second print.
biosimilar aflibercept possibly imminent, Opthea more valuable to Regeneron?, page-18
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
89.5¢ |
Change
-0.015(1.65%) |
Mkt cap ! $1.101B | |||
| Open | High | Low | Value | Volume |
| 91.0¢ | 92.0¢ | 87.5¢ | $1.496M | 1.676M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1705 | 89.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 90.5¢ | 46363 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| OPT (ASX) Chart |